Fasting Comparative Bioavailability Study of 2 Meloxicam 15 mg Tablets in Healthy Volunteers Under Fasting Condition
Condition(s):PharmacokineticsLast Updated:November 18, 2021Completed
Hide Studies Not Open or Pending
Condition(s):PharmacokineticsLast Updated:November 18, 2021Completed
Condition(s):Metastatic Melanoma; Advanced Melanoma; Metastatic Melanoma Stratified by MHC-II ExpressionLast Updated:April 20, 2021Terminated
Condition(s):Chronic Lymphocytic Leukemia; Lymphoma; Multiple MyelomaLast Updated:February 17, 2011Completed
Condition(s):Hypertension; HypercholesterolemiaLast Updated:August 23, 2023Completed
Condition(s):MelanomaLast Updated:November 18, 2023Withdrawn
Condition(s):Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative NeoplasmsLast Updated:June 8, 2015Terminated
Condition(s):Solid TumorLast Updated:April 4, 2023Recruiting
Condition(s):Type 1 Diabetes MellitusLast Updated:March 15, 2012Completed
Condition(s):Hematologic MalignanciesLast Updated:October 4, 2023Recruiting
Condition(s):Metastatic Melanoma; Unresectable Melanoma; MelanomaLast Updated:March 27, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.